Skip to main content

Table 1 Patient Characteristics

From: Establishing a whole blood CD4+ T cell immunity measurement to predict response to anti-PD-1

Patient characteristics

n = 59

Age, years

 

 Median

69

 Range

47–86

Sex, n (%)

 

 Male

50 (84.7)

 Female

9 (15.3)

Histology, n (%)

 

 Adeno

26 (44.1)

 Squamous

16 (27.1)

 NOS

17 (28.8)

Smoking history, n (%)

 

 Current or former smoker

52 (88.1)

 Never smoked

7 (11.9)

Disease stage, n (%)

 

 C-stage IIIB

5 (8.5)

 C-stage IV

41 (69.5)

 Recurrence

13 (22.0)

PD-L1 TPS, n (%)

 

 50% or greater

57 (96.6)

 1–49%

2 (3.4)

Best response, n (%)

 

 CR or PR

21 (35.6)

 SD

17 (28.8)

 PD

12 (20.3)

 NE

9 (15.3)

  1. C-stage, clinical stage; CR, complete response; NE, not evaluable; NOS, not otherwise specified; PD, progressive disease; PR, partial response; SD, stable disease